|

Boswellia serrata 2% topical cream Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Youssef Hashem Hafez1

Indications

  • Radiodermatitis1
  • Head and Neck Neoplasms1
  • Cancer1

Other1 trial

Topical Boswellia Serrata 2% to Prevent Radiation Dermatitis in Head and Neck Cancer
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.